0

Insights Blog

Explore our thought leadership insights, as life science technologies evolve and accelerate.
Filters
Reset All
Search
Industries
Insight Type
Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | August Roundup
August was a month that had some significant new therapeutic approvals as well as company launches, in addition to several financing rounds and partnerships. Read below to find out more about these new key developments.
September 1, 2022
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | August Roundup
August was a month that had some significant new therapeutic approvals as well as company launches, in addition to several financing rounds and partnerships. Read below to find out more about these new key developments.
September 1, 2022
Next-Generation Therapeutics
Blog Article
Clinical Diagnostics
Decibio Analytics launches inaugural NGS Oncology DxBook
Discover the new DxBook for clinical NGS oncology testing.
August 31, 2022
Blog Article
Clinical Diagnostics
Decibio Analytics launches inaugural NGS Oncology DxBook
Discover the new DxBook for clinical NGS oncology testing.
August 31, 2022
DxBooks Data Insights
DeciBio News
DeciBio Data Insights
Clinical Diagnostics
Liquid Biopsy
Blog Article
Clinical Diagnostics
Multiplex Tissue Analysis & Digital Pathology Trial Analysis
The accumulation of biomarker-matched clinical outcome data may imply that a new diagnostic is poised to approach the clinic.
August 31, 2022
Blog Article
Clinical Diagnostics
Multiplex Tissue Analysis & Digital Pathology Trial Analysis
The accumulation of biomarker-matched clinical outcome data may imply that a new diagnostic is poised to approach the clinic.
August 31, 2022
Digital Pathology
DeciBio Q&A
Clinical Diagnostics
The Promise of Clinical Digital Pathology: DeciBio's Q&A with Mark Lloyd of Inspirata
Read as our experts interview Mark Lloyd, Executive Vice President and Founder of Inspirata, about the promise of Clinical Digital Pathology.
August 30, 2022
DeciBio Q&A
Clinical Diagnostics
The Promise of Clinical Digital Pathology: DeciBio's Q&A with Mark Lloyd of Inspirata
Read as our experts interview Mark Lloyd, Executive Vice President and Founder of Inspirata, about the promise of Clinical Digital Pathology.
August 30, 2022
Digital Pathology
Precision Medicine
Clinical Diagnostics
Blog Article
Clinical Diagnostics
The Partnerships Setting the Stage for the Digital Pathology Revolution
Our experts took a look at digital pathology partnerships more broadly, to identify the companies and collaborations that are enabling more widespread access to digital pathology tools.
August 24, 2022
Blog Article
Clinical Diagnostics
The Partnerships Setting the Stage for the Digital Pathology Revolution
Our experts took a look at digital pathology partnerships more broadly, to identify the companies and collaborations that are enabling more widespread access to digital pathology tools.
August 24, 2022
Digital Pathology
Clinical Diagnostics
In The Press
The Top 50 Healthcare Leaders in Consulting of 2022
Partners, Andrew Aijian and Stephane Budel, place in The Consulting Report's, "The Top 50 Healthcare Leaders in Consulting of 2022".
August 24, 2022
In The Press
The Top 50 Healthcare Leaders in Consulting of 2022
Partners, Andrew Aijian and Stephane Budel, place in The Consulting Report's, "The Top 50 Healthcare Leaders in Consulting of 2022".
August 24, 2022
DeciBio News
Life Science Consulting
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions